SG11201401351PA - 4-amino-3-phenylamino-6-phenylpyrazolo[3,4-d] pyrimidine derivatives, their manufacture and their use as antiviral active substances - Google Patents

4-amino-3-phenylamino-6-phenylpyrazolo[3,4-d] pyrimidine derivatives, their manufacture and their use as antiviral active substances

Info

Publication number
SG11201401351PA
SG11201401351PA SG11201401351PA SG11201401351PA SG11201401351PA SG 11201401351P A SG11201401351P A SG 11201401351PA SG 11201401351P A SG11201401351P A SG 11201401351PA SG 11201401351P A SG11201401351P A SG 11201401351PA SG 11201401351P A SG11201401351P A SG 11201401351PA
Authority
SG
Singapore
Prior art keywords
phenylpyrazolo
phenylamino
amino
manufacture
active substances
Prior art date
Application number
SG11201401351PA
Inventor
Peter Wutzler
Michaela Schmidtke
Vadim Makarov
Original Assignee
Dritte Patentportfolio Beteiligungs Gmbh & Co Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE201110116373 external-priority patent/DE102011116373A1/en
Application filed by Dritte Patentportfolio Beteiligungs Gmbh & Co Kg filed Critical Dritte Patentportfolio Beteiligungs Gmbh & Co Kg
Publication of SG11201401351PA publication Critical patent/SG11201401351PA/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/16Antivirals for RNA viruses for influenza or rhinoviruses
SG11201401351PA 2011-10-14 2012-10-15 4-amino-3-phenylamino-6-phenylpyrazolo[3,4-d] pyrimidine derivatives, their manufacture and their use as antiviral active substances SG11201401351PA (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE201110116373 DE102011116373A1 (en) 2011-10-14 2011-10-14 Preparing substituted amino-phenylamino-phenyl-pyrazolo(3,4-d)pyrimidine derivatives useful e.g. for treating picornavirus infection, comprises reacting substituted amino-phenylamino-pyrazole-carbonitrile compounds and benzamidine compounds
DE102011116384 2011-10-20
PCT/EP2012/070403 WO2013053942A1 (en) 2011-10-14 2012-10-15 4-amino-3-phenylamino-6-phenylpyrazolo[3,4-d] pyrimidine derivatives, their manufacture and their use as antiviral active substances

Publications (1)

Publication Number Publication Date
SG11201401351PA true SG11201401351PA (en) 2014-08-28

Family

ID=47071252

Family Applications (2)

Application Number Title Priority Date Filing Date
SG11201401351PA SG11201401351PA (en) 2011-10-14 2012-10-15 4-amino-3-phenylamino-6-phenylpyrazolo[3,4-d] pyrimidine derivatives, their manufacture and their use as antiviral active substances
SG10201602846TA SG10201602846TA (en) 2011-10-14 2012-10-15 4-amino-3-phenylamino-6-phenylpyrazolo[3,4-d]pyrimidine derivatives, their manufacture and use as antiviral agents

Family Applications After (1)

Application Number Title Priority Date Filing Date
SG10201602846TA SG10201602846TA (en) 2011-10-14 2012-10-15 4-amino-3-phenylamino-6-phenylpyrazolo[3,4-d]pyrimidine derivatives, their manufacture and use as antiviral agents

Country Status (22)

Country Link
US (1) US9790225B2 (en)
EP (1) EP2766367B1 (en)
JP (1) JP6071012B2 (en)
KR (1) KR20140095467A (en)
CN (1) CN103946224A (en)
AU (1) AU2012322750B2 (en)
BR (1) BR112014008815B1 (en)
CA (1) CA2850439C (en)
DK (1) DK2766367T3 (en)
ES (1) ES2924828T3 (en)
HR (1) HRP20220928T1 (en)
HU (1) HUE059217T2 (en)
IL (1) IL231934A (en)
LT (1) LT2766367T (en)
MX (1) MX2014003987A (en)
PL (1) PL2766367T3 (en)
PT (1) PT2766367T (en)
RU (1) RU2014118953A (en)
SG (2) SG11201401351PA (en)
SI (1) SI2766367T1 (en)
WO (1) WO2013053942A1 (en)
ZA (1) ZA201402226B (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2662822T3 (en) 2015-03-04 2018-04-09 Scandion Oncology A/S 4-Amino-3-phenylamino-6-phenylpyrazol [3,4-d] pyrimidine derivatives for use as BCRP inhibitors in therapeutic treatments
KR102205570B1 (en) 2018-09-12 2021-01-20 김홍기 Root plant hydroponic cultivation sheet

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2965643A (en) 1960-12-20 Derivatives of pyrazolo
US3551428A (en) 1956-02-10 1970-12-29 Ciba Geigy Corp New 1- (or 2-) substituted 4-mercapto-pyrazolo(3,4-d)pyrimidines
DE3712735A1 (en) 1987-04-15 1988-11-10 Boehringer Mannheim Gmbh NEW PYRAZOLO (3,4-D) PYRIMIDINE, METHOD FOR THE PRODUCTION AND USE THEREOF AS A MEDICINAL PRODUCT
CA2100863A1 (en) 1991-01-23 1992-07-24 David A. Bullough Adenosine kinase inhibitors
TW444018B (en) * 1992-12-17 2001-07-01 Pfizer Pyrazolopyrimidines
US5646152A (en) 1994-06-15 1997-07-08 Pfizer Inc. Methods of administering CRF antagonists
CZ27399A3 (en) 1999-01-26 2000-08-16 Ústav Experimentální Botaniky Av Čr Substituted nitrogen heterocyclic derivatives process of their preparation, the derivatives employed as medicaments, pharmaceutical composition and a compound pharmaceutical preparation in which these derivatives are comprised as well as use of these derivatives for preparing medicaments
DE102006029074A1 (en) * 2006-06-22 2007-12-27 Friedrich-Schiller-Universität Jena 4-Amino-3-arylamino-6-arylpyrazolo [3,4-d] pyrimidine derivatives, process for their preparation and their use as antiviral agents

Also Published As

Publication number Publication date
AU2012322750A1 (en) 2014-04-24
PT2766367T (en) 2022-08-12
CA2850439A1 (en) 2013-04-18
HUE059217T2 (en) 2022-10-28
PL2766367T3 (en) 2022-08-22
ZA201402226B (en) 2015-05-27
KR20140095467A (en) 2014-08-01
BR112014008815A2 (en) 2017-04-25
IL231934A (en) 2017-03-30
MX2014003987A (en) 2014-09-22
BR112014008815B1 (en) 2021-01-12
ES2924828T3 (en) 2022-10-11
LT2766367T (en) 2022-08-25
US20140296259A1 (en) 2014-10-02
NZ623573A (en) 2016-08-26
RU2014118953A (en) 2015-11-20
CN103946224A (en) 2014-07-23
EP2766367B1 (en) 2022-05-18
US9790225B2 (en) 2017-10-17
EP2766367A1 (en) 2014-08-20
SG10201602846TA (en) 2016-05-30
IL231934A0 (en) 2014-05-28
CA2850439C (en) 2020-04-07
DK2766367T3 (en) 2022-08-01
JP2014528468A (en) 2014-10-27
AU2012322750B2 (en) 2016-11-10
WO2013053942A1 (en) 2013-04-18
JP6071012B2 (en) 2017-02-01
SI2766367T1 (en) 2022-10-28
HRP20220928T1 (en) 2022-10-28

Similar Documents

Publication Publication Date Title
IL257410A (en) Pyrazolo [1, 5 -a] pyrimidines as antiviral agents
HRP20180771T1 (en) Pyrrolo[3,2-d]pyrimidine derivatives for the treatment of viral infections and other diseases
EP2751112A4 (en) Substituted pyrazolo[3,4-d]pyrimidines and uses thereof
HK1176236A1 (en) Thiazolo[5,4-d] pyrimidines and their use as agrochemicals [54-d]
IL240877A0 (en) Triazolo [4, 5-d] pyrimidine derivatives, their preparation and pharmaceutical compositions containing them
PT2794611T (en) Pyrazolo[1,5-a]pyrimidines as antiviral agents
IL229606A0 (en) Pyrazolo [3,4-d] pyrimidine compounds and their use as pde2 inhibitors and/or cyp3a4 inhibitors
IL227526A0 (en) 6-cyclobutyl-1,5-dihydro-pyrazolo [3,4-d]pyrimidin-4-one derivatives their use as pde9a inhibitors
AP2012006631A0 (en) 6-Cycloalkyl-1, 5-dihydro-pyrazolo[3,4-D] pyrimidin-4-one derivatives and their use as PDE9A inhibitors
IL233808B (en) Triazolo[4,5-d]pyrimidine derivatives and medicaments containing them
HK1193806A1 (en) Thieno[2,3-d]pyrimidine derivatives and their use to treat arrhythmia [23-d]
PT2920174T (en) Substituted pyrazolo[3,4-d]pyrimidine compounds, their preparation and use as sigma receptors ligands
ZA201402226B (en) 4-amino-3-phenylamino-6-phenylpyrazolo[3,4-d] pyrimidine derivatives, their manufacture and their use as antiviral active substances